Escherichia Coli (O104:H4) ATCC BAA-2326 - 01104L -  - MDL-MOG01104L
Escherichia Coli (O104:H4) ATCC BAA-2326 - 01104L -  - MDL-MOG01104L

Escherichia Coli (O104:H4) ATCC BAA-2326 - 01104L - - MDL-MOG01104L

Lyfod ATCC BAA-2326 Escherichia coli, 6/Vial

Lyfod ATCC BAA-2326 Escherichia coli, 6/VialTRUE E.coli ATCC BAA-2326 Clinical laboratories are the front line...

Price :
Regular price $550.99
Regular price $550.99

MICROBIOLOGICS INC

MDL-MOG01104L

In Stock Sold Out 95

Notify Me

Lyfod ATCC BAA-2326 Escherichia coli, 6/VialTRUE
  • E.coli ATCC BAA-2326
  • Clinical laboratories are the front line in detecting Shiga toxin-producing Escherichia coli (STEC) disease
  • They are responsible for the initial detection of suspect cases by testing primary specimens
  • The Centers for Disease Control (CDC) recommends that, "All stools submitted for testing from patients with acute community-acquired diarrhea should be cultured for STEC O157
  • These stools should be simultaneously assayed for non-O157 STEC with a test that detects Shiga toxins or the genes encoding these toxins"
  • Microbiologics is the world's first and only supplier to offer O157 and non-O157 Shiga toxin-producing E. coli (STEC) in easy-to-use, prepared formats for quality control testing
  • Clinical testing laboratories can utilize STEC QC microorganisms from Microbiologics to validate, verify and perform routine quality control checks of their STEC test methods